Johns Hopkins researchers have unveiled groundbreaking maps of mouse brains, created using 3D imaging, specialized microscopes, and artificial intelligence (AI). These maps, published on February 18 in the journal Cell, pinpoint the precise locations of over 10 million oligodendrocytes—cells essential for forming myelin, the protective sheath around nerve cell axons. This sheath is crucial for the rapid transmission of electrical signals and overall brain health.
Funded by the National Institutes of Health, these maps not only offer a comprehensive view of myelin distribution across brain circuits but also shed light on the implications of oligodendrocyte loss in human diseases such as multiple sclerosis, Alzheimer’s disease, and other disorders affecting learning, memory, sensory ability, and movement. Although mouse and human brains differ, they share numerous characteristics and biological processes.
Revolutionizing Brain Mapping with Advanced Techniques
“Our study identifies not only the location of oligodendrocytes in the brain but also integrates information about gene expression and the structural features of neurons,” says Dwight Bergles, Ph.D., a professor at the Johns Hopkins University School of Medicine. “It’s like mapping the location of all the trees in a forest, but also adding information about soil quality, weather, and geology to understand the forest ecosystem.”
The newly developed maps provide higher resolution and better coverage of gray matter than previous versions. Myelin in gray matter is notoriously difficult to visualize using traditional techniques like MRI. Gray matter is home to most of the brain’s neurons and is responsible for controlling movement and other vital functions.
“Because myelin can speed communication between neurons, these maps of regional differences in myelin patterning may help us understand how different parts of the brain accomplish different tasks,” says Bergles.
Collaborative Efforts and Technological Innovations
The project was a collaborative effort involving Bergles’ team and experts in biomedical engineering and computer science. Yu Kang T. Xu, a Ph.D. student and Kavli Neuroscience Discovery Institute fellow, played a pivotal role in developing a novel pipeline. This involved tissue clearing to remove fatty deposits that obscure deep brain structures and light-sheet microscopy for rapid scanning of brain tissues.
Machine learning technology was crucial for cataloging over 10 million cells per mouse brain across various conditions and time spans. This AI-driven approach enabled the automatic identification of oligodendrocytes and the reconstruction of brain-wide maps, image by image.
Insights into Developmental Patterns
Each map charts oligodendrocyte positions over the mouse lifespan, from two months to two years. The study found that while oligodendrocytes steadily increased with age, the rate of new cell and myelin formation varied significantly across different brain regions. Areas with initially slow oligodendrocyte addition continued this trend, suggesting a rigid developmental program.
“It will be interesting to use this approach to see how different life experiences, such as stress, social interaction, and learning affect these patterns,” Bergles notes.
Implications for Neurological Diseases
The research also revealed that brain regions receiving direct sensory input had three times more oligodendrocytes than areas like the primary motor cortex. This may reflect the brain’s need for rapid processing of sensory information, such as touch, sound, and sight.
In experiments where mice were exposed to chemicals that destroy oligodendrocytes and myelin, the scientists identified regions of higher vulnerability and resilience. These findings could offer clues for preserving myelin in diseases like multiple sclerosis.
Furthermore, in a mouse model of Alzheimer’s disease, the team discovered that myelin damage was not confined to areas near amyloid-beta plaques but also occurred in white matter regions with diffuse plaques. This increased vulnerability may explain the prevalence of oligodendrocyte dysfunction in Alzheimer’s disease.
Future Directions and Accessibility
The newly published oligodendrocyte maps are available for free exploration by other scientists, with the hope that this resource will accelerate new discoveries. This work was supported by the National Institutes of Health, the Chan Zuckerberg Initiative, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and the Kavli Neuroscience Discovery Institute.
The announcement of these advanced maps represents a significant leap forward in understanding brain structure and function, offering promising avenues for research into neurological disorders.
